Sorafgen-200

Packed:

120 Tablets

Manufacturer:

Hetero Labs Limited

Active ingredient:

Sorafenib

Sorafenib Sorafgen-200 is indicated as a treatment for advanced renal cell carcinoma (RCC), unresectable hepatocellular carcinomas (HCC) and thyroid cancer.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Sorafgen-200”

Your email address will not be published. Required fields are marked *